Integra LifeSciences (IART) Tops Q2 EPS by 1c; Updates FY11 Outlook, Revs Above Street

July 28, 2011 8:14 AM EDT Send to a Friend
Get Alerts IART Hot Sheet
Trade IART Now!
Join SI Premium – FREE
Integra LifeSciences Holdings (NASDAQ: IART) reported Q2 EPS of $0.70, $0.01 better than the analyst estimate of $0.69. Revenue for the quarter came in at $193.3 million versus the consensus estimate of $188.78 million.

Integra LifeSciences Holdings sees FY2011 EPS of $2.92-$3.02, versus the consensus of $2.98. Integra LifeSciences Holdings sees FY2011 revenue of $785-$800 million, versus the consensus of $783.55 million.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance

Add Your Comment